Streamlining Devices Used by Seniors to Improve Quality of Life with Gary Rotman and Bruce Barnet SiMPL Technology TRANSCRIPT
Gary Rotman and Bruce Barnet are Co-Founders of SiMPL Technology, a company designing and selling simple tech products for seniors and their caregivers. With a particular focus on people with cognitive challenges and discomfort with digital technology, SiMPL is bringing solutions to the market that solve such challenges...
Streamlining Devices Used by Seniors to Improve Quality of Life with Gary Rotman and Bruce Barnet SiMPL Technology
Gary Rotman and Bruce Barnet are Co-Founders of SiMPL Technology, a company designing and selling simple tech products for seniors and their caregivers. With a particular focus on people with cognitive challenges and discomfort with digital technology, SiMPL is bringing solutions to the market that solve such challenges...
Precision Intracoronary Imaging Software Powers Understanding of Optical Coherence Tomography with Dr. Nick West Abbott TRANSCRIPT
Dr. Nick West is the Chief Medical Officer and DVP Global Medical Affairs for Vascular at Abbott. With the launch of the Ultreon software 1.0, Abbott is bringing a new level of analysis to their Optical Coherence Tomography intracoronary imaging tool.
Precision Intracoronary Imaging Software Powers Understanding of Optical Coherence Tomography with Dr. Nick West Abbott
Dr. Nick West is the Chief Medical Officer and DVP Global Medical Affairs for Vascular at Abbott. With the launch of the Ultreon software 1.0, Abbott is bringing a new level of analysis to their Optical Coherence Tomography intracoronary imaging tool.
Developing Inhibitor Drugs for Use with Antibiotics to Combat Antimicrobial Drug Resistance with Dr. Mike Dudley Qpex Biopharma TRANSCRIPT
Dr. Mike Dudley is President and CEO of QpexBiopharma and seeing drug-resistant infections occurring inside the hospital as well as outside the hospital. Qpex is developing IV and oral drugs that are designed to overcome resistance mechanisms in bacteria that render penicillin-like drugs inactive.
What is empowered patient podcast?
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
Who is the CEO of CTMA?
Pierre Pellier is CEO of CTMA and is driven to provide better access to innovative and potentially life-saving therapies to more patients. The key is to shorten the duration of clinical trials by more quickly and efficiently identifying and recruiting potentially eligible participants. Using the CT-Scout platform on a mobile device, doctors are prompted to ask, during a consultation, a few selected questions to determine whether a particular patient might be eligible for any of the numerous...
Who is Jennifer Gudeman?
Dr. Jennifer Gudeman was hired for the newly formed role of Vice President, Medical and Clinical Affairs at Avadel Pharmaceuticals. We talk about the clinical development of their lead investigational product FT218 to treat the rare disease narcolepsy. Optimized the drug delivery release of sodium oxybate with their proprietary controlled-release technology allows for a single bedtime dose. While the FDA nearly 20 years ago approved sodium oxybate to treat cataplexy and excessive daytime...
Reducing Costs of Manufacturing Facilitates Broader Access to Transformative CAR-T Cell and Other Gene Therapies with Boro Dropulić Caring Cross TRANSCRIPT
Boro Dropulić is the Co-Founder and Executive Director of Caring Cross, a 501 (c) (3) non-profit dedicated to accelerating the development and manufacturing of advanced medicines to improve access to cures for all patients independent of where they live.
Reducing Costs of Manufacturing Facilitates Broader Access to Transformative CAR-T Cell and Other Gene Therapies with Boro Dropulić Caring Cross
Boro Dropulić is the Co-Founder and Executive Director of Caring Cross, a 501 (c) (3) non-profit dedicated to accelerating the development and manufacturing of advanced medicines to improve access to cures for all patients independent of where they live.
Developing Immunotherapies Using Oncolytic Viruses to Change the Tumor Microenvironment with Dr. Paul Peter Tak Candel Therapeutics TRANSCRIPT
Dr. Paul Peter Tak is the President and CEO of Candel Therapeutics which is focused on educating the immune system to recognize and kill tumor cells in patients with a solid tumor. Candel is developing immunotherapies using engineered oncolytic viruses for prostate cancer, brain cancer, lung cancer, pancreatic cancer,...
Developing Allogeneic Induced Pluripotent Stem Cell Based Therapies to Kill Cancer Cells with Kleanthis Xanthopoulos Shoreline Biosciences TRANSCRIPT
Kleanthis Xanthopoulos is Co-Founder and CEO of Shoreline Biosciences. He talks about the Shoreline cell therapy platform that uses standardized manufacturing of allogeneic induced pluripotent stem cells to create an effective treatment to kill tumor cells with multiple advantages over autologous...
